| Jansen JP, Kumar R, Carmeli Y
Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK. [Journal Article]
Pharmacoeconomics 2009; 27(12):1045-56.
Abstract | Full Citation |
| de Lalla F
Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem. [Journal Article]
Ther Clin Risk Manag 2009.:829-39.
Abstract | Full Citation |
| Burkhardt O, Kumar V, Schmidt S, et al.
Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations. [LETTER]
Int J Antimicrob Agents 2009 Nov 5.
Full Citation |
| Almuzara M, Limansky A, Ballerini V, et al.
In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods. [JOURNAL ARTICLE]
Int J Antimicrob Agents 2009 Nov 2.
Abstract | Full Citation | Find Related Articles |
| Cuzon G, Naas T, Nordmann P
[KPC carbapenemases: What issue in clinical microbiology?] [JOURNAL ARTICLE]
Pathol Biol (Paris) 2009 Oct 23.
Abstract | Full Citation | Find Related Articles |
| Torralba MA, Matía M, Gómez Del Valle C, et al.
[Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?] [LETTER]
Med Clin (Barc) 2009 Oct 9.
Full Citation | Find Related Articles |
| Lee CH, Su LH, Lin WC, et al.
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen. [JOURNAL ARTICLE]
Int J Infect Dis 2009 Sep 30.
Abstract | Full Citation |
| Goldstein EJ, Citron DM, Peraino V, et al.
Introduction of ertapenem onto a hospital formulary: Effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Sep 28.
Abstract | Full Citation | Find Related Articles |
| Chen LR, Zhou HW, Cai JC, et al.
Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate. [Journal Article]
Diagn Microbiol Infect Dis 2009 Oct; 65(2):163-7.
Abstract | Full Citation | Find Related Articles |
| Hawser SP, Bouchillon SK, Hoban DJ, et al.
In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study. [JOURNAL ARTICLE]
Int J Antimicrob Agents 2009 Sep 10.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
